Phase IIb Study of Intranasal Glutathione in Parkinson's Disease.

J Parkinsons Dis · 2017 · PMC5438472 · PMID 28436395

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The greatest change observed was a 90-point reduction in DE in the high-dose (in)GSH arm, although this reduction did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.